Evidence map›Paper›PMID 38514887›Full record

ArticleNature immunology2024

An immunophenotype-coupled transcriptomic atlas of human hematopoietic progenitors.

Xuan Zhang, Baobao Song, Maximillian J Carlino, Guangyuan Li, Kyle Ferchen, Mi Chen, Evrett N Thompson, Bailee N Kain, Dan Schnell, Kairavee Thakkar and 16 more

Registry-linked trialOpen access · hybridAbstract read
In one paragraph

Article in Nature immunology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07527247 (Using AS01 Adjuvant to Improve Immune Response in Older Adults Through Trained Immunity), which is not on this map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
14.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07527247 phase2recruitingnot on this mapstarted 2025, after this paper: background citation

Using AS01 Adjuvant to Improve Immune Response in Older Adults Through Trained Immunity

TypeinterventionalSponsorSingapore General HospitalRan2025 to 2029Enrolled40ConditionsImmune System Responses and Trained Immunity After AS01 Administration, Healthy AdultArmsAS01 adjuvant (0.5 mL intramuscular), YF17D (Stamaril, Sanofi-Pasteur), Placebo (NaCl 09%, 0.5mL)
3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 65 citations in OpenAlex.

  1. Immunophenotyping by Single-Cell CITE-Seq.Methods in molecular biology (Clifton, N.J.) · 2027
    Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

26 authors at 5 institutions in 1 country.

Xuan Zhang *Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0001-7966-8748
Baobao Song *Division of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0002-0062-2710
Maximillian J CarlinoYale Stem Cell Center, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0003-1578-8024
Guangyuan LiDivision of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Kyle FerchenDivision of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0002-3470-3623
Mi ChenYale Stem Cell Center, Yale School of Medicine, New Haven, CT, USA.
Evrett N ThompsonYale Stem Cell Center, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-6271-5392
Bailee N KainDivision of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Dan SchnellDivision of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID http://orcid.org/0000-0001-5829-1830
Kairavee ThakkarDivision of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Michal KourilDivision of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Kang JinDivision of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Stuart B HayDivision of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Sidharth SenDivision of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
David BernardiciusDivision of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.ORCID http://orcid.org/0009-0001-5380-2002
Siyuan MaDivision of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Sierra N BennettDivision of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Josh CroteauBioLegend, Inc., San Diego, CA, USA.ORCID http://orcid.org/0000-0002-8142-0482
Ornella SalvatoriBioLegend, Inc., San Diego, CA, USA.ORCID http://orcid.org/0009-0007-2613-8998
Melvin H LyeCuriox Biosystems, Inc., Woburn, MA, USA.
Austin E GillenDivision of Hematology, University of Colorado School of Medicine, Aurora, CO, USA.
Craig T JordanDivision of Hematology, University of Colorado School of Medicine, Aurora, CO, USA.
Harinder SinghDepartments of Immunology and Computational and Systems Biology, Center for Systems Immunology, University of Pittsburgh, Pittsburgh, PA, USA.ORCID http://orcid.org/0000-0002-6330-8526
Diane S KrauseYale Stem Cell Center, Yale School of Medicine, New Haven, CT, USA.ORCID http://orcid.org/0000-0001-9420-6947
Nathan SalomonisDivision of Biomedical Informatics, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. nathan.salomonis@cchmc.org.ORCID http://orcid.org/0000-0001-9689-2469
H Leighton GrimesDivision of Immunobiology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA. lee.grimes@cchmc.org.ORCID http://orcid.org/0000-0001-8162-6758
Cincinnati Children's Hospital Medical Center · USYale Cancer Center · USBioLegend (United States) · USUniversity of Colorado Denver · USUniversity of Pittsburgh · US

Funding

Yale Pathology Tissue Services Shared ResourceP30CA016359 · NCI · YALE UNIVERSITY · PI MEGAN C KING · 1985 to 2026
$85.0M
ENVIRONMETAL CARCINOGENESIS AND MUTAGENESIST32ES007250 · NIEHS · UNIVERSITY OF CINCINNATI · PI MILLER, WILLIAM E · 1988 to 2024
$11.9M
Yale Cooperative Hematology Specialized Core CenterU54DK106857 · NIDDK · YALE UNIVERSITY · PI JOHN HWA, Diane S Krause · 2015 to 2026
$9.7M
Therapeutic Targeting of Human AML Stem CellsR35CA242376 · NCI · UNIVERSITY OF COLORADO DENVER · PI Craig T. Jordan · 2020 to 2026
$5.6M
Mechanisms of granulocyte homeostasisR01HL122661 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI H. LEIGHTON GRIMES, Nathan G. Salomonis · 2015 to 2026
$5.3M
A generalizable framework for linking single-cell genomic states with cell fate outcomes in hematopoiesisRC2DK122376 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI GRIMES, H. LEIGHTON · 2020 to 2024
$5.3M
Xenotransplant and Genome Editing CoreU54DK126108 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Daniel Starczynowski, YI ZHENG · 2021 to 2026
$5.0M
Modeling myelodysplasiaR01CA253981 · NCI · CINCINNATI CHILDRENS HOSP MED CTR · PI GRIMES, H. LEIGHTON, HALENE, STEPHANIE · 2021 to 2025
$2.9M
Towards an inclusive genomic risk classification for acute myeloid leukemia (AML)R01CA284595 · NCI · OHIO STATE UNIVERSITY · PI Ann-Kathrin Eisfeld, H. LEIGHTON GRIMES · 2023 to 2026
$2.6M
ZE5 Analytical CytometerS10OD025045 · OD · CINCINNATI CHILDRENS HOSP MED CTR · PI THORNTON, SHERRY L · 2018 to 2018
$359k
Establishing the role and mechanisms of LSD1 during megakaryocytic and erythroid fate commitmentF31HL167628 · NHLBI · YALE UNIVERSITY · PI THOMPSON, EVRETT · 2023 to 2025
$155k
Cellular Heterogeneity and Aging in MDS and AMLIK2BX004952 · VA · VA EASTERN COLORADO HEALTH CARE SYSTEM · PI GILLEN, AUSTIN E · 2021 to 2025
–
BLRD VA IK2 BX004952NCI NIH HHS P30 CA016359NCI NIH HHS R01 CA253981NCI NIH HHS R01 CA284595NCI NIH HHS R35 CA242376NHLBI NIH HHS F31 HL167628NHLBI NIH HHS R01 HL122661NIDDK NIH HHS RC2 DK122376NIDDK NIH HHS U54 DK106857NIDDK NIH HHS U54 DK126108NIEHS NIH HHS T32 ES007250NIH HHS S10 OD025045
6 · The paper itself

Abstract

Analysis of the human hematopoietic progenitor compartment is being transformed by single-cell multimodal approaches. Cellular indexing of transcriptomes and epitopes by sequencing (CITE-seq) enables coupled surface protein and transcriptome profiling, thereby revealing genomic programs underlying progenitor states. To perform CITE-seq systematically on primary human bone marrow cells, we used titrations with 266 CITE-seq antibodies (antibody-derived tags) and machine learning to optimize a panel of 132 antibodies. Multimodal analysis resolved >80 stem, progenitor, immune, stromal and transitional cells defined by distinctive surface markers and transcriptomes. This dataset enables flow cytometry solutions for in silico-predicted cell states and identifies dozens of cell surface markers consistently detected across donors spanning race and sex. Finally, aligning annotations from this atlas, we nominate normal marrow equivalents for acute myeloid leukemia stem cell populations that differ in clinical response. This atlas serves as an advanced digital resource for hematopoietic progenitor analyses in human health and disease.

Indexed as

Hematopoietic Stem CellsTranscriptomeBone MarrowBone Marrow CellsGene Expression ProfilingHumans

Identifiers

PMID38514887
PMCPMC11003869
OpenAlexW4393043550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.